Skip to content

N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine.

Anne Nathalia De Sousa-Silva, Clarissa de Almeida Moura, Carina Ioná De Oliveira Torres, Vitória Barros Marques, Jayane M Do Nascimento Silva, Bruno Lobão-Soares, Sérgio Ruschi Silva, Nicole L Galvão-Coelho, Fernanda Palhano-Fontes, Dráulio Barros de Araújo, Edilson Dantas Da Silva, Elaine C Gavioli

Neuropharmacology July 1, 2026 DOI: 10.1016/j.neuropharm.2026.110947 via PubMed

Summary

AI-generated from the abstract

In helpless mice, the psychedelic compound N,N-dimethyltryptamine (DMT) produced rapid and long-lasting antidepressant effects comparable to the fast-acting antidepressant S-ketamine. DMT at 10 mg/kg reversed escape deficits and reduced immobility in several behavioral tests, with effects lasting up to 8 days, whereas S-ketamine's effects lasted up to 30 hours. DMT also showed anxiolytic-like effects, reversing stress-induced hypolocomotion and increasing open-arm exploration, while S-ketamine did not. Neither drug altered behavior in the novelty-suppressed feeding test. These findings suggest DMT has transdiagnostic therapeutic potential for stress-related disorders.

Study at a glance

Characteristics Animal study Peer reviewed
Population Male helpless mice (single-housed and group-housed)
Interventions DMT S-ketamine
Dose 10 or 25 mg/kg (ip) for DMT; 10 or 30 mg/kg (ip) for S-ketamine
Duration Up to 8 days post-injection
Topics Anxiety Depression
Keywords Animal models Mouse N,N-Dimethyltryptamine
Citations 1
Key finding DMT is as effective as S-ketamine in producing rapid and long-lasting antidepressant effects in helpless mice, and also shows anxiolytic-like effects.

Abstract

N,N-dimethyltryptamine (DMT) is an naturally occurring indoleamine with hallucinogenic and antidepressant effects in humans. Here, we compared the effects of DMT and S-ketamine, a fast-acting antidepressant, in helpless mice. To induce helplessness, male single and group-housed mice were exposed to inescapable footshock stress; only helpless animals were subsequently treated with S-ketamine 10 or 30 mg/kg (ip), DMT 10 or 25 mg/kg (ip), or vehicle and tested in behavioral assays. In depressive-related behavioral tests, S-ketamine and DMT (both at 10 mg/kg), only in group-housed mice, 24 h after administration, reversed escape deficits and reduced escape latency in the learned helplessness model. In helpless single-housed mice, 5 days after drug administration, both compounds (at 10 mg/kg) prevented stress-induced anhedonia in the sucrose preference test. In the tail suspension test, DMT (10 mg/kg) reduced immobility up to 8 days post-injection, whereas the effects of S-ketamine (30 mg/kg) lasted up to 30 h after injection. In anxiety-related behavioral tests, DMT (10 mg/kg), but not S-ketamine, reversed stress-induced hypolocomotion in the open field test, and increased exploration in open arms in the elevated plus-maze up to 5 days post-administration. However, in the novelty-suppressed feeding behavior, at 8 days after drug administration, neither DMT nor S-ketamine altered mouse behavior. Collectively, DMT is as effective as S-ketamine in producing rapid and long-lasting antidepressant effects in helpless mice. Present data also suggest anxiolytic-like effects for DMT. Ultimately, main findings highlight the transdiagnostic therapeutic potential of DMT for stress-related disorders.

Explore topics

Comments

No comments yet.

Log in to comment